EP4322769A4 - Compositions de traitement d'infections par vih - Google Patents

Compositions de traitement d'infections par vih

Info

Publication number
EP4322769A4
EP4322769A4 EP22788771.8A EP22788771A EP4322769A4 EP 4322769 A4 EP4322769 A4 EP 4322769A4 EP 22788771 A EP22788771 A EP 22788771A EP 4322769 A4 EP4322769 A4 EP 4322769A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treatment
hiv infections
hiv
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22788771.8A
Other languages
German (de)
English (en)
Other versions
EP4322769A1 (fr
Inventor
Yuntao Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virongy Biosciences Inc
Original Assignee
Virongy Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virongy Biosciences Inc filed Critical Virongy Biosciences Inc
Publication of EP4322769A1 publication Critical patent/EP4322769A1/fr
Publication of EP4322769A4 publication Critical patent/EP4322769A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
EP22788771.8A 2021-04-12 2022-04-12 Compositions de traitement d'infections par vih Pending EP4322769A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163173554P 2021-04-12 2021-04-12
PCT/US2022/024425 WO2022221282A1 (fr) 2021-04-12 2022-04-12 Compositions de traitement d'infections par vih

Publications (2)

Publication Number Publication Date
EP4322769A1 EP4322769A1 (fr) 2024-02-21
EP4322769A4 true EP4322769A4 (fr) 2025-06-04

Family

ID=83640962

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22788771.8A Pending EP4322769A4 (fr) 2021-04-12 2022-04-12 Compositions de traitement d'infections par vih

Country Status (3)

Country Link
EP (1) EP4322769A4 (fr)
CN (1) CN118076242A (fr)
WO (1) WO2022221282A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160124436A (ko) * 2015-04-20 2016-10-28 정세헌 기능성 식품 및 이의 제조방법
WO2021177553A1 (fr) * 2020-03-05 2021-09-10 남종현 Composition de thé efficace pour prévenir ou améliorer des maladies respiratoires, et composition pharmaceutique la comprenant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696094B2 (en) * 2000-10-18 2004-02-24 Tzu-Sheng Wu Herbal pharmaceutical composition for treatment of HIV/AIDS patients
US7008650B2 (en) * 2001-08-09 2006-03-07 Lam Paul Y S Compositions for the treatment of acquired immunodeficiency disease
CN1411866A (zh) * 2002-11-24 2003-04-23 赵锡全 根除hiv/aids艾滋病毒的中药及制备方法
KR100512096B1 (ko) * 2003-06-26 2005-09-05 한국과학기술연구원 항바이러스 활성을 가지는 화합물 및 이를 포함하는 국화 추출물
CN102883727B (zh) * 2009-12-30 2016-09-21 培力有限公司 预防和治疗病毒感染的方法和物质
CN103446202B (zh) * 2012-05-29 2018-11-06 江中药业股份有限公司 一种预防和治疗艾滋病的组合物及其制备方法
FR3034625A1 (fr) * 2015-04-10 2016-10-14 Naturex Solvant eutectique d'extraction, procede d'extraction par eutectigenese utilisant ledit solvant, et extrait issu dudit procede d'extraction.
MY205266A (en) * 2019-04-06 2024-10-10 Cargill Inc Methods for making botanical extract composition
CN111228391A (zh) * 2020-01-16 2020-06-05 北京生道久健康科技有限公司 一种抗艾滋病病毒的复方制剂及其制备方法和应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160124436A (ko) * 2015-04-20 2016-10-28 정세헌 기능성 식품 및 이의 제조방법
WO2021177553A1 (fr) * 2020-03-05 2021-09-10 남종현 Composition de thé efficace pour prévenir ou améliorer des maladies respiratoires, et composition pharmaceutique la comprenant
EP4115895A1 (fr) * 2020-03-05 2023-01-11 Jong Hyun Nam Composition de thé efficace pour prévenir ou améliorer des maladies respiratoires, et composition pharmaceutique la comprenant

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
KWON EUN-BIN ET AL: "A Herbal Mixture Formula of OCD20015-V009 Prophylactic Administration to Enhance Interferon-Mediated Antiviral Activity Against Influenza A Virus", FRONTIERS IN PHARMACOLOGY, vol. 12, 24 November 2021 (2021-11-24), CH, XP093243155, ISSN: 1663-9812, DOI: 10.3389/fphar.2021.764297 *
LIU ZHI-BIN ET AL: "Effectiveness and safety of traditional Chinese medicine in treating acquired immune deficiency syndrome: 2004-2014", INFECTIOUS DISEASES OF POVERTY, vol. 4, no. 1, 1 December 2015 (2015-12-01), London, UK, XP093243205, ISSN: 2049-9957, DOI: 10.1186/s40249-015-0093-6 *
SALEHI BAHARE ET AL: "Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 19, no. 5, 14 May 2018 (2018-05-14), Basel, CH, pages 1459, XP093243194, ISSN: 1422-0067, DOI: 10.3390/ijms19051459 *
See also references of WO2022221282A1 *
WHO: "Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine", 10 October 2003 (2003-10-10), XP093243165, Retrieved from the Internet <URL:https://iris.who.int/bitstream/handle/10665/43029/9241546433_eng.pdf?sequence=1&isAllowed=y> *
YANG QIAN ET AL: "Inhibition of porcine reproductive and respiratory syndrome virus replication by flavaspidic acid AB", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 97, no. 1, 21 November 2012 (2012-11-21), pages 66 - 73, XP028962518, ISSN: 0166-3542, DOI: 10.1016/J.ANTIVIRAL.2012.11.004 *

Also Published As

Publication number Publication date
EP4322769A1 (fr) 2024-02-21
CN118076242A (zh) 2024-05-24
WO2022221282A1 (fr) 2022-10-20

Similar Documents

Publication Publication Date Title
EP4157272C0 (fr) Remdésivir pour le traitement des infections virales
EP3996716C0 (fr) Composés s&#39;utilisant pour traiter les infections causées par le virus de la grippe
EP4373480A4 (fr) Traitement de la dépression
EP4352042A4 (fr) Composés pour le traitement du sras
EP4172157C0 (fr) Inhibiteurs de capside pour le traitement du vih
EP4250932A4 (fr) Compositions bactériennes conçues pour traiter une maladie du greffon contre l&#39;hôte
EP4096675C0 (fr) Compositions pour le traitement de la covid longue
EP4436667C0 (fr) Composés de pipérazinylsulfonylaryle pour le traitement d&#39;infections bactériennes
EP4508077A4 (fr) Compositions pour prévenir ou traiter des infections par la grippe
EP4440574A4 (fr) Utilisation de pipendoxifène pour traiter une infection par sars-cov-2
EP4426682A4 (fr) Inhibiteurs du sars-cov-2 pour le traitement d&#39;infections à coronavirus
EP3709968C0 (fr) Émulsions destinés au traitement d&#39;infections vaginales
EP4337174A4 (fr) Méthodes et compositions pour le traitement d&#39;infections virales
EP4262812A4 (fr) Promédicaments de 6-aza-nucléoside comme agents antiviraux pour le traitement d&#39;infections virales
EP4142728C0 (fr) 6&#39;-méthoxycinchonan-9-ols pour le traitement d&#39;infections à coronavirus
EP4117654C0 (fr) Compositions pour traiter une infection et interrompre la formation de biofilm
EP4034108A4 (fr) Composés d&#39;azaindole carboxamide pour le traitement d&#39;infections mycobactériennes
EP4125893A4 (fr) Technologies de prévention ou de traitement d&#39;infections
EP3618826C0 (fr) Compositions pour le traitement des infections pathogènes
EP4096783A4 (fr) Compositions pour le traitement des hémorroïdes
EP4149451A4 (fr) Cystéamine pour le traitement d&#39;une infection par sras-cov-2
EP4121084A4 (fr) Compositions pour le traitement d&#39;une infection des voies respiratoires et leurs utilisations
EP4129291A4 (fr) Médicament de traitement d&#39;une infection à coronavirus
EP4210720C0 (fr) Compositions probiotiques pour le traitement de l&#39;acné
EP4121092C0 (fr) Interferons hybrides pour le traitement d&#39;infections virales

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20231113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A23L0033000000

Ipc: A61K0036068000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/734 20060101ALI20250206BHEP

Ipc: A61K 36/62 20060101ALI20250206BHEP

Ipc: A61K 36/481 20060101ALI20250206BHEP

Ipc: A61K 36/355 20060101ALI20250206BHEP

Ipc: A61K 36/287 20060101ALI20250206BHEP

Ipc: A61K 9/00 20060101ALI20250206BHEP

Ipc: A61K 36/074 20060101ALI20250206BHEP

Ipc: A23L 33/00 20160101ALI20250206BHEP

Ipc: A61K 36/068 20060101AFI20250206BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20250507

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/734 20060101ALI20250429BHEP

Ipc: A61K 36/62 20060101ALI20250429BHEP

Ipc: A61K 36/481 20060101ALI20250429BHEP

Ipc: A61K 36/355 20060101ALI20250429BHEP

Ipc: A61K 36/287 20060101ALI20250429BHEP

Ipc: A61K 9/00 20060101ALI20250429BHEP

Ipc: A61K 36/074 20060101ALI20250429BHEP

Ipc: A23L 33/00 20160101ALI20250429BHEP

Ipc: A61K 36/068 20060101AFI20250429BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20260303